On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayDec 29, 2017 9:44 am

CannabisNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Visits Clinical Trial Facility in San Juan, Puerto Rico

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that it has completed a prestudy visit of the Fundación de Investigación (“FDI”) facilities in San Juan, Puerto Rico. Per the release, this will be the site where the company’s research arm, Cannevert Therapeutics Ltd. (“CTL”), will be conducting its first human study of CTL-X, a cannabis strain targeting the pain management market. Speaking about the FDI clinical trial facility in this morning's update, Veritas CEO Lui Franciosi stated, “I was very impressed by their Phase I and Phase II-III clinical trial…

Continue Reading

ThursdayDec 28, 2017 11:29 am

CannabisNewsBreaks – AppSwarm, Inc. (SWRM) Has Finger on Pulse of Burgeoning Mobile Gaming Industry

As gaming, and mobile gaming in particular, approaches an expected $110 billion in revenues worldwide this year, developer and publisher AppSwarm (OTC: SWRM) is working to incubate new talent as it acquires apps for all mobile devices. The company also announced the development of a joint roll-out of mobile applications for the purchase of cannabis using bitcoin payment options and blockchain technology, in conjunction with SinglePoint, Inc. (OTC: SING). Article discussing this reads: “The global gaming industry is expected to grow by almost eight percent over 2016 and to generate a total of approximately $110 billion in revenues this year,…

Continue Reading

ThursdayDec 28, 2017 10:16 am

CannabisNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Subsidiary Receives Dealer License from Health Canada

Emerging-stage pharmaceutical and IP development company Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) this morning announced that Health Canada has issued its research and development subsidiary, Cannevert Therapeutics Ltd. (“CTL”), a dealer license allowing it to possess, analyze, sale, send, transport and deliver cannabis, hemp and related products. Per the release, reception of this license marks a “significant step” for CTL as it seeks to discover and develop new therapeutic cannabis strains while also providing commercial chemical and biological testing services for licensed producers under Health Canada guidelines. “We are excited that Cannevert scientists will now not only…

Continue Reading

WednesdayDec 27, 2017 12:16 pm

CannabisNewsBreaks – Medical Cannabis Payment Solutions (REFG) Serving Cannabis Industry with Merchant Processing Power

As attention grows in regard to the possibilities for a legal marketplace serving the varied needs of the medical and recreational marijuana industries, Medical Cannabis Payment Solutions (OTC: REFG) is positioning itself to compete in the industry verticals serving cannabis patients and corporate clients. An article discussing this reads: “In response to the need for a private encrypted digital solution, REFG is positioned in the industry as a first-tier merchant processing pioneer. REFG, through subsidiary StateSourced, has launched the first and only comprehensive card processing system of its kind. With considerable investment in market research and product development, the company…

Continue Reading

WednesdayDec 27, 2017 11:55 am

CannabisNewsBreaks – CNBC Publication Highlights SinglePoint, Inc.’s (SING) SingleSeed as Alternative for Cash-only Cannabis Industry

SinglePoint’s (OTC: SING) mobile app SingleSeed is gaining attention thanks to a CNBC article on its ability to help cannabis dispensaries and customers exchange funds through bitcoin. Using debit or credit cards, consumers can make purchases without the need to rely on conventional banks that may be reluctant to transact business with the cannabis industry amid ongoing controversy about federal drug policy. An article discussing this reads: “It was obvious banks didn’t want to handle legal marijuana transactions, … which meant cannabis retailers and consumers were forced to bring cash to the table, and it was apparent that an alternative…

Continue Reading

WednesdayDec 27, 2017 11:33 am

CannabisNewsBreaks – Global Payout, Inc. (GOHE) CEO Releases Letter to Shareholders

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced the release of a year-end letter to shareholders from CEO James Hancock. In the letter, Hancock recaps what he calls an “especially active, yet successful” year for both Global Payout and its majority-owned subsidiary, MoneyTrac Technology, Inc. In particular, he notes the company’s appointment of Vanessa Luna to the position of chief operating officer as a major milestone in Global Payout’s strategic plans. “Without question, one of the most critical events of the year involved the appointment of Ms. Vanessa Luna as Global's Chief Operating Officer,” Hancock stated in…

Continue Reading

TuesdayDec 26, 2017 12:44 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Set to Exploit the Cannabis Industry Utilizing Proprietary Technology

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is well positioned in the booming cannabis industry with its patent-protected technology, DehyraTECH™, which enables a more efficient delivery and absorption of cannabinoids. An article discussing this reads: “Lexaria research and development partnership with the Canadian government’s National Research Council underscores the significance of its unique technology. Results from the endeavor are expected to support accelerating B2B relationships – and not just in the booming cannabis and CBD/hemp oil industry. Much more can be done to enhance and enable delivery of active pharmaceutical ingredients in a wide variety of important health-related fields, offering Lexaria…

Continue Reading

TuesdayDec 26, 2017 12:38 pm

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Centers Focus on Cryptocurrency Division

ChineseInvestors.com, Inc. (OTCQB: CIIX), a diverse educational and consulting company for the Chinese-speaking community in China and the U.S., recently announced that it is spinning off two divisions to allow itself to focus on its new cryptocurrency division. The company is spinning off its wholly-owned foreign entity, CBD Biotechnology Co., Ltd., and its wholly-owned subsidiary, ChineseHempOil.com. An article discussing plans this reads: “It has committed itself to cryptocurrency education and active involvement. It broadcasts a daily video from the NYSE titled ‘Bitcoin MultiMillionaire’. It has also recently reached agreement to host a bitcoin ATM in the lobby of its headquarters…

Continue Reading

TuesdayDec 26, 2017 9:51 am

CannabisNewsBreaks – EVIO, Inc. (EVIO) Licensee Attains ISO 17025 Accreditation

EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced that its Colorado licensee, PhytaTech CO, has attained ISO 17025 accreditation, which requires consistent production of precise and accurate tests and implementation of a rigorous quality management system. Per the update, ISO 17025 is the highest recognized quality standard for calibration and testing laboratories. “As one of only a few Colorado Cannabis Testing labs that have achieved ISO 17025 accreditation, PhytaTech is at the leading edge of testing in the state,” Stephen Goldman, PhytaTech’s…

Continue Reading

TuesdayDec 26, 2017 9:11 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Looks to Blockchain Technology as Possible Solution for Issues Facing Cannabis Industry

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced plans to leverage its existing team of technology and health care experts in order to develop methods of utilizing blockchain technology in areas such as product identification assurance (PIA). The importance of PIA was reaffirmed in a recent study published by JAMA, which indicated that nearly 70 percent of all cannabidiol products sold online are mislabeled. “We understand the unique challenges facing the cannabis industry and believe that our team has the expertise to be the first to…

Continue Reading

Contact us: 303.498.7722